AtriCure
ATRC
$23.37
Share price
0.86%
Change (1 day)
-46.87%
Change (1 year)
Categories
P/S ratio for AtriCure (ATRC)
P/S ratio as of April 2024 (TTM): 2.81
According to AtriCure's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.8074. At the end of 2023 the company had a P/S ratio of 4.24.
P/S ratio history for AtriCure from 2005 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.24 | -32.18% |
| 2022 | 6.25 | -46.33% |
| 2021 | 11.6 | -4.07% |
| 2020 | 12.1 | 117.27% |
| 2019 | 5.59 | -4.66% |
| 2018 | 5.86 | 62.78% |
| 2017 | 3.60 | -14.18% |
| 2016 | 4.19 | -24.86% |
| 2015 | 5.58 | 8.95% |
| 2014 | 5.12 | -3.4% |
| 2013 | 5.30 | 219.54% |
| 2012 | 1.66 | -40.73% |
| 2011 | 2.80 | 2.72% |
| 2010 | 2.73 | 60.32% |
| 2009 | 1.70 | 196.51% |
| 2008 | 0.5735 | -85.05% |
| 2007 | 3.84 | 37.85% |
| 2006 | 2.78 | -32.05% |
| 2005 | 4.09 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.79 | 34.85% | 🇺🇸 USA |
 Medtronic MDT | 3.28 | 16.69% | 🇮🇪 Ireland |
 Abiomed ABMD | 16.0 | 469.76% | 🇺🇸 USA |
 Boston Scientific BSX | 7.55 | 169.03% | 🇺🇸 USA |
 Edwards Lifesciences EW | 8.66 | 208.61% | 🇺🇸 USA |
 Teleflex TFX | 3.27 | 16.59% | 🇺🇸 USA |
 Cooper Companies COO | 4.82 | 71.55% | 🇺🇸 USA |